Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07283341 · ClinicalTrials.gov registry record
Diet and Motility in IBS
A clinical trial of Irritable Bowel Syndrome (IBS), sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- 90
- Enrollment target
- 1
- Study location
NCT07283341: Recruiting study of Irritable Bowel Syndrome (IBS), sponsored by Children's Hospital of Philadelphia.
NCT07283341 is a study of Irritable Bowel Syndrome (IBS) that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 90 participants, below the 1,171-participant average among 5 other Irritable Bowel Syndrome (IBS) trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07283341, a study of Irritable Bowel Syndrome (IBS), is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to identify factors that influence symptoms in children with irritable bowel syndrome (IBS), to find ways to make diet treatments work better and possibly create personalized plans to help each child with IBS feel better. The main question it aims to answer is: 1. What types of food do the kids eat and how do these diets relate to their symptoms? 2. Is there any motility pattern that we can identify from the kids with or without IBS using a wearable patch? 3. What kinds of bacteria and chemicals are found in the gut and urine of children with IBS, and how are these linked to their IBS symptoms? Participants will use the wearable patch, answer questionnaires, collect stool and urine samples, and recall their 24 hours dietary.
Primary Outcome
Differences in total activity, pre- and post-prandial activity ratios, nighttime colonic activity, and night-to-day colonic activity ratios between IBS patients and controls. WPS reading will be completed after each study visit. Differences will be compared at the 3rd and 4th quarters of each year.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Wireless Patch System
Study Locations (1)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2023-07-31 |
| Est. Completion | 2027-06 |
What NCT07283341 shows while recruiting
NCT07283341 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,171-participant average among 5 other Irritable Bowel Syndrome (IBS) trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Irritable Bowel Syndrome (IBS) appearing as the primary indexed condition, and to 1 intervention - of which Wireless Patch System is the first listed.
NCT07283341 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07283341 about?
NCT07283341 is a clinical study titled "Diet and Motility in IBS". The goal of this observational study is to identify factors that influence symptoms in children with irritable bowel syndrome (IBS), to find ways to make diet treatments work better and possibly create personalized plans to help each child with IBS feel better. The main question it aims to answer is...
What is the current status of trial NCT07283341?
This trial is currently recruiting. The enrollment target is 90 participants. The study started on 2023-07-31. Estimated completion is 2027-06.
What conditions does trial NCT07283341 study?
This clinical trial studies the following conditions: Irritable Bowel Syndrome (IBS).
What interventions are being tested in trial NCT07283341?
The interventions under investigation include: Wireless Patch System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07283341?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07283341 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Irritable Bowel Syndrome (IBS)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome
RECRUITING · NA
-
Prospective Observational Study of Naturopathic Approaches to IBS
RECRUITING
-
Irritable Bowel Syndrome and Control Volunteers: Diet Challenge
RECRUITING · NA
-
Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI